Platelet and fibrinogen kinetic studies were carried out in patients with valvular heart diseases and without any episodes of thromboembolism.
Platelet kinetic studies using Cr-51 labeled platelets were performed by recommended method of international committee for standardization in hematology and fibrinogen kinetic studies using commercially prepared I-125 labeled fibrinogen were performed by Bradley's method.
Mean platelet survival time was slightly shortened in patients with mitral stenosis (6.2+0.9 days, N=7), comparing with the normal value (8. 7+0.3 days, N=6), and not shortened in patients with mitral regurgitation (7. 3+1.3 days, N=3) or aortic valvular diseases (8.7+0.3 days, N=3).
Platelet turnover was not accelerated in all patients with valvular heart diseases. Fibrinogen half clearance time was shortened in patients with mitral stenosis (3.0+0.5 days, N=8), comparing with the normal value (4.1+0.1 days, N=6), and not shortened in patients with aortic valvular diseases (3.6+0.6 days, N=5).
Fibrinogen turnover was accelerated in all patients with valvular heart diseases. Fibrinogen half clearance time in patients with prosthetic mitral valve was shorter and fibrinogen turnover was more accelerated than the values before replacement. Blood & Vessel 1981 12: 29 
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